COVID-19- to COVID-20

October 07, 2020

From Covid-19- to COVID-20 - the evolution of COVID-19 in terms of its overall medical and socio-economic impacts is examine through a comparison of cases and deaths in the two successive waves we have experienced. Peak comparisons show that although the number of cases has doubled the number of deaths has decreased by 50 percent with case mortality decreasing by a factor of four. In addition, where at the beginning of the pandemic interventions were aimed at containment and mitigation of a single disease entity, today we are addressing concurrent co-morbidities which are largely attributable to social determinants of health and the collateral morbidities resulting from our interventions. Overall, we are currently dealing more with a "syndemic" and a name change should be considered for many reasons.

A brief commentary on how the above needs to be considered as we draw closer to having a vaccine for which an equitable allocation plan must be developed. This is a pressing need as projections indicate that initially only a limited supply will be available.
-end-
About the Journal

Disaster Medicine and Public Health Preparedness is the first comprehensive and authoritative journal emphasizing public health preparedness and disaster response for all health care and public health professionals globally. The journal seeks to translate science into practice and integrate medical and public health perspectives. DMPHP is the official journal of the Society for Disaster Medicine and Public Health.

About the Society

The Society for Disaster Medicine and Public Health aims to evolve a discipline around disaster medicine and public health. The society's goal is to improve global health security, with the involvement and development of global health professionals and others who are involved in responding to and or managing significant events. The mission of the SDMPH is to advance and promote excellence in education, training and research in disaster medicine and public health for all potential health system responders based on sound educational principles, scientific evidence and best clinical and public health practices.

Society for Disaster Medicine and Public Health, Inc.

Related Vaccine Articles from Brightsurf:

Who should get the COVID-19 vaccine first?
Nineteen global health experts from around the world have proposed a new, three-phase plan for vaccine distribution -- called the Fair Priority Model -- which aims to reduce premature deaths and other irreversible health consequences from COVID-19.

Breakthrough with cancer vaccine
Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers.

How to improve the pneumococcus vaccine
Pneumococcus kills 1 million children annually according to the World Health Organization.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
In a new study, published April 7 in mBio, researchers from the University of Iowa and the University of Georgia demonstrate that a new vaccine fully protects mice against a lethal dose of MERS, a close cousin of COVID-19.

Coronavirus Vaccine: Where are we and what's next? (video)
You might have heard that COVID-19 vaccine trials are underway in Seattle.

Why isn't there a vaccine for staph?
A study from Washington University School of Medicine in St.

Exposing vaccine hesitant to real-life pain of diseases makes them more pro-vaccine
New research from Brigham Young University professors finds there is a better way to help increase support for vaccinations: Expose people to the pain and suffering caused by vaccine-preventable diseases instead of trying to combat people with vaccine facts.

Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.

On the horizon: An acne vaccine
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.

Read More: Vaccine News and Vaccine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.